This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,009.65 firm fixed-price delivery order is for the provision of the medication Kyleena 19.5 mg systems, with a performance period through December 30, 2024.
DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue delivery orders for a comprehensive range of pharmaceutical products to support the medical supply needs of military health facilities. This specific award is not associated with a set-aside designation, allowing DMS Pharmaceutical Group to leverage its woman-owned small business status to secure direct federal contracts across various medical product categories. As a key supplier in the federal pharmaceutical supply chain, DMS Pharmaceutical Group provides branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to the Department of Defense.
Generated 3/7/25, 10:04 AM